These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 21148651)
21. Anesthetic and pharmacologic considerations in perioperative care of obese children. Chidambaran V; Tewari A; Mahmoud M J Clin Anesth; 2018 Mar; 45():39-50. PubMed ID: 29275265 [TBL] [Abstract][Full Text] [Related]
22. [Pharmacokinetics of anesthesia related drugs in patients with chronic kidney disease]. Tsubokawa T Masui; 2013 Nov; 62(11):1293-303. PubMed ID: 24364270 [TBL] [Abstract][Full Text] [Related]
23. Neuromuscular effects of cisatracurium in morbidly obese patients. Salihoĝlu Z; Demiroluk S; Köse Y; Zengin K; Taskin M; Gökay BV Middle East J Anaesthesiol; 2008 Feb; 19(4):831-9. PubMed ID: 18630769 [TBL] [Abstract][Full Text] [Related]
24. Anesthesia in the obese patient: pharmacokinetic considerations. Casati A; Putzu M J Clin Anesth; 2005 Mar; 17(2):134-45. PubMed ID: 15809132 [TBL] [Abstract][Full Text] [Related]
25. Postoperative analgesia in a morbidly obese patient with chronic renal failure. Daszkiewicz A; Wyleżoł M Anestezjol Intens Ter; 2010; 42(4):197-200. PubMed ID: 21252836 [TBL] [Abstract][Full Text] [Related]
28. Opioids, hypnotics and muscle relaxants: an update on pharmacokinetics and techniques of administration. Crankshaw D; Purcell G Anaesth Intensive Care; 1987 Feb; 15(1):5-6. PubMed ID: 2882703 [No Abstract] [Full Text] [Related]
29. Pharmacokinetics of analgesics, sedatives and anaesthetic agents during cardiopulmonary bypass. Gedney JA; Ghosh S Br J Anaesth; 1995 Sep; 75(3):344-51. PubMed ID: 7547056 [TBL] [Abstract][Full Text] [Related]
30. Population based pharmacokinetic analysis: why do we need it; what is it; and what has it told us about anaesthetics? Wright PM Br J Anaesth; 1998 Apr; 80(4):488-501. PubMed ID: 9640156 [No Abstract] [Full Text] [Related]
31. Clinical pharmacokinetics of drugs in obesity. An update. Cheymol G Clin Pharmacokinet; 1993 Aug; 25(2):103-14. PubMed ID: 8403734 [TBL] [Abstract][Full Text] [Related]
32. The effective effect-site propofol concentration for induction and intubation with two pharmacokinetic models in morbidly obese patients using total body weight. Echevarría GC; Elgueta MF; Donoso MT; Bugedo DA; Cortínez LI; Muñoz HR Anesth Analg; 2012 Oct; 115(4):823-9. PubMed ID: 22956531 [TBL] [Abstract][Full Text] [Related]
33. Clinical Practice Guidelines for Sustained Neuromuscular Blockade in the Adult Critically Ill Patient. Murray MJ; DeBlock H; Erstad B; Gray A; Jacobi J; Jordan C; McGee W; McManus C; Meade M; Nix S; Patterson A; Sands MK; Pino R; Tescher A; Arbour R; Rochwerg B; Murray CF; Mehta S Crit Care Med; 2016 Nov; 44(11):2079-2103. PubMed ID: 27755068 [TBL] [Abstract][Full Text] [Related]
34. Randomized comparison of sugammadex and neostigmine for reversal of rocuronium-induced muscle relaxation in morbidly obese undergoing general anaesthesia. Gaszynski T; Szewczyk T; Gaszynski W Br J Anaesth; 2012 Feb; 108(2):236-9. PubMed ID: 22012861 [TBL] [Abstract][Full Text] [Related]
35. Propofol clearance in morbidly obese children and adolescents: influence of age and body size. Diepstraten J; Chidambaran V; Sadhasivam S; Esslinger HR; Cox SL; Inge TH; Knibbe CA; Vinks AA Clin Pharmacokinet; 2012 Aug; 51(8):543-51. PubMed ID: 22690673 [TBL] [Abstract][Full Text] [Related]
36. Prevalence and mechanisms of diurnal hypercapnia in a sample of morbidly obese subjects with obstructive sleep apnoea. Resta O; Foschino-Barbaro MP; Bonfitto P; Talamo S; Legari G; De Pergola G; Minenna A; Giorgino R Respir Med; 2000 Mar; 94(3):240-6. PubMed ID: 10783935 [TBL] [Abstract][Full Text] [Related]